Cargando…

Diagnostic value of using exosome-derived cysteine-rich protein 61 as biomarkers for acute coronary syndrome

Acute coronary syndrome (ACS) is the main manifestation of cardiovascular disease and the primary cause of adult hospitalization in China. There is an urgent demand for novel biomarkers for the diagnosis of ACS. Although plasma cysteine-rich protein 61 (Cyr61) has been previously reported to be accu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wei, Li, Yi, Zhi, Wei, Liu, Chen, Fan, Weize, Miao, Qing, Gu, Xinshun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549088/ https://www.ncbi.nlm.nih.gov/pubmed/34721679 http://dx.doi.org/10.3892/etm.2021.10872

Ejemplares similares

Cysteine-rich 61 (Cyr61): a biomarker reflecting disease activity in rheumatoid arthritis
por: Fan, Yong, et al.
Publicado: (2019)

Urinary Cysteine-Rich Protein 61 and Trefoil Factor 3 as Diagnostic Biomarkers for Colorectal Cancer()
por: Shimura, Takaya, et al.
Publicado: (2019)

Critical Role of Cysteine-Rich Protein 61 in Mediating the Activation of Renal Fibroblasts
por: Liu, Hang, et al.
Publicado: (2019)

Role of cysteine-rich angiogenic inducer 61 in fibroblast-like synovial cell proliferation and invasion in rheumatoid arthritis
por: JIE, LI-GANG, et al.
Publicado: (2015)

Role of cysteine-rich angiogenic inducer 61 in fibroblast-like synovial cell proliferation and invasion in rheumatoid arthritis
por: Jie, Li-Gang, et al.
Publicado: (2022)

Cysteine-rich 61 (Cyr61) upregulated in pulmonary arterial hypertension promotes the proliferation of pulmonary artery smooth muscle cells
por: Gao, Lan, et al.
Publicado: (2017)

Cysteine-Rich Angiogenic Inducer 61 Serves as a Potential Serum Biomarker for the Remission of Adult-Onset Still's Disease
por: Su, Yutong, et al.
Publicado: (2019)

Prognostic significance of expression of cysteine-rich 61 and cyclooxygenase-2 in gastric cancer
por: Wang, Yan, et al.
Publicado: (2016)

Blood‐based detection of lung cancer using cysteine‐rich angiogenic inducer 61 (CYR61) as a circulating protein biomarker: a pilot study
por: Ac\ˇkar, Lucija, et al.
Publicado: (2021)

Cysteine-Rich Angiogenic Inducer 61: Pro-Survival Function and Role as a Biomarker for Disseminating Breast Cancer Cells
por: Bartkowiak, Kai, et al.
Publicado: (2021)

Cysteine-Rich Protein 61 Plays a Proinflammatory Role in Obstructive Kidney Fibrosis
por: Lai, Chun-Fu, et al.
Publicado: (2013)

Efficacy and safety of intracoronary prourokinase during percutaneous coronary intervention in treating ST-segment elevation myocardial infarction patients: a randomized, controlled study
por: Wu, Yanqiang, et al.
Publicado: (2020)

Study of Cysteine-Rich Protein 61 Genetic Polymorphism in Predisposition to Fracture Nonunion: A Case Control
por: Ali, Sabir, et al.
Publicado: (2015)

Cysteine‐Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary Syndromes
por: Klingenberg, Roland, et al.
Publicado: (2021)

Targeting cysteine-rich angiogenic inducer-61 by antibody immunotherapy suppresses growth and migration of non-small cell lung cancer
por: Li, Xinpeng, et al.
Publicado: (2018)

Targeting cysteine-rich angiogenic inducer-61 by antibody immunotherapy suppresses growth and migration of non-small cell lung cancer
por: Li, Xinpeng, et al.
Publicado: (2022)

Serum exosomal microRNA-146a as a novel diagnostic biomarker for acute coronary syndrome
por: Li, Long-Jun, et al.
Publicado: (2021)

Dickkopf-1/cysteine-rich angiogenic inducer 61 axis mediates palmitic acid-induced inflammation and apoptosis of vascular endothelial cells
por: Gan, Yi-Rong, et al.
Publicado: (2021)

Diagnostic and prognostic value of secreted protein acidic and rich in cysteine in the diffuse large B-cell lymphoma
por: Pan, Peng-Ji, et al.
Publicado: (2021)

The value of urinary exosomal lncRNA SNHG16 as a diagnostic biomarker for bladder cancer
por: Liu, Chengyi, et al.
Publicado: (2023)

Cysteine‐rich protein 61 regulates the chemosensitivity of chronic myeloid leukemia to imatinib mesylate through the nuclear factor kappa B/Bcl‐2 pathway
por: Song, Yanfang, et al.
Publicado: (2019)

Cross-sectional and longitudinal associations of serum Cysteine-rich 61 with severity and prognosis among community-acquired pneumonia patients in China
por: Yao, Meng-Xing, et al.
Publicado: (2022)

Circulating Exosomal CircRNAs as Diagnostic Biomarkers for Chronic Coronary Syndrome
por: Liu, Xiaoyan, et al.
Publicado: (2023)

Advances in Exosomes as Diagnostic and Therapeutic Biomarkers for Gynaecological Malignancies
por: Miao, Mengdan, et al.
Publicado: (2022)

Anticancer Activity of Metformin, an Antidiabetic Drug, Against Ovarian Cancer Cells Involves Inhibition of Cysteine-Rich 61 (Cyr61)/Akt/Mammalian Target of Rapamycin (mTOR) Signaling Pathway
por: Zhang, Fengli, et al.
Publicado: (2018)

Retracted: Anticancer Activity of Metformin, an Antidiabetic Drug, Against Ovarian Cancer Cells Involves Inhibition of Cysteine-Rich 61 (Cyr61)/Akt/Mammalian Target of Rapamycin (mTOR) Signaling Pathway
por: Zhang, Fengli, et al.
Publicado: (2021)

PIK3R1Met326Ile germline mutation correlates with cysteine-rich protein 61 expression and poor prognosis in glioblastoma
por: Otani, Yoshihiro, et al.
Publicado: (2017)

Activating transcription factor 3 inhibits angiotensin II-induced cardiomyocyte viability and fibrosis by activating the transcription of cysteine-rich angiogenic protein 61
por: Zhang, Yu, et al.
Publicado: (2022)

Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells
por: Chin, Li-Han, et al.
Publicado: (2015)

Secreted Protein Acidic and Rich in Cysteine as a Molecular Physiological and Pathological Biomarker
por: Ghanemi, Abdelaziz, et al.
Publicado: (2021)

Exosomes in Nephropathies: A Rich Source of Novel Biomarkers
por: Masaoutis, Christos, et al.
Publicado: (2020)

Cysteine and homocysteine as biomarker of various diseases
por: Rehman, Tahniat, et al.
Publicado: (2020)

Correction: Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells
por: Chin, Li-Han, et al.
Publicado: (2017)

Identification of the potential biomarkers associated with circadian rhythms in heart failure
por: Sun, Qiang, et al.
Publicado: (2023)

CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma
por: Wei, Jing, et al.
Publicado: (2016)

Oxidant Exposure Induces Cysteine-Rich Protein 61 (CCN1) via c-Jun/AP-1 to Reduce Collagen Expression in Human Dermal Fibroblasts
por: Qin, Zhaoping, et al.
Publicado: (2014)

Associations between urinary cysteine-rich protein 61 excretion and kidney function decline in outpatients with chronic kidney disease: a prospective cohort study in Taiwan
por: Lai, Chun-Fu, et al.
Publicado: (2021)

Identification of SEC61G as a Diagnostic and Prognostic Biomarker in Oral Squamous Cell Carcinoma
por: Zhang, Shi-Long, et al.
Publicado: (2023)

Identification of exosomal miRNAs as diagnostic biomarkers for cholangiocarcinoma and gallbladder carcinoma
por: Xue, Xin-ying, et al.
Publicado: (2020)

Exosomes in Coronary Artery Disease
por: Gao, Xiao-Fei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l12ame6duitqt6kfuo5r3fk068